title: Cardiac hypertrophy in neonatal nephrectomized rats: the role of the sympathetic nervous system.
abstract: Cardiac hypertrophy is frequently encountered in patients with renal failure and represents an independent risk factor for cardiovascular morbidity and mortality. The pathogenesis of cardiac hypertrophy is related to multiple factors, including excess adrenergic activity. This study investigated how renal injury in the early stages of life affects the adrenergic system and thereby potentially influences cardiac growth. Biomarkers of cardiac hypertrophy were used to assess adrenergic function. Newborn male Sprague-Dawley rats were allocated to three groups of five rats each: 5/6 nephrectomy (Nx), pair-fed controls (PF), and sham-operated (SH). Nx animals had significantly higher plasma urea nitrogen, serum creatinine, and mean arterial blood pressure. The heart-weight/body-weight ratio of the Nx cohort was higher than SH and PF (p < 0.001) groups. Plasma norepinephrine (NE) of Nx animals was almost twofold higher than SH and PF (p < 0.01) animals. Compared with SH and PF, Nx animals had higher alpha1A-receptor protein expression, lower cardiac beta1- and beta2-receptor protein expression (p < 0.05), but higher G-protein-coupled receptor kinase-2 (GRK2) expression (p < 0.05). Norepinephrine transporter protein (NET) and renalase protein expression in cardiac tissue from Nx pups were significantly lower than SH and PF. Our data suggest that early age Nx animals have increased circulating catecholamines due to decreased NE metabolism. Enhancement of cardiac GRK2 and NE can contribute to cardiac hypertrophy seen in Nx animals. Furthermore, AKT (activated via alpha1A receptors), as well as increased alpha1A receptors and their agonist NE, might contribute to the observed hypertrophy.
authors.affiliation: Division of Nephrology, VCU Medical Center, Virginia Commonwealth University, MCV Station, Box 980160, Richmond, VA, 23298-0160, USA. ssghosh@hsc.vcu.edu
authors.forename: Siddhartha S
authors.initials: SS
authors.lastname: Ghosh
authors.forename: Richard J
authors.initials: RJ
authors.lastname: Krieg
authors.forename: Domenic A
authors.initials: DA
authors.lastname: Sica
authors.forename: Ruipeng
authors.initials: R
authors.lastname: Wang
authors.forename: Itaf
authors.initials: I
authors.lastname: Fakhry
authors.forename: Todd
authors.initials: T
authors.lastname: Gehr
mesh_terms: D000818:Animals; D000831:Animals, Newborn; D015415:Biomarkers / Q000378:metabolism; D001794:Blood Pressure; D006332:Cardiomegaly / Q000378:metabolism* / Q000473:pathology / Q000503:physiopathology*; D048049:Extracellular Signal-Regulated MAP Kinases / Q000378:metabolism; D005260:Female; D054769:G-Protein-Coupled Receptor Kinase 2 / Q000378:metabolism; D006977:Hypertension, Renal / Q000378:metabolism / Q000503:physiopathology; D008297:Male; D009392:Nephrectomy; D050484:Norepinephrine Plasma Membrane Transport Proteins / Q000378:metabolism; D009929:Organ Size; D011247:Pregnancy; D051057:Proto-Oncogene Proteins c-akt / Q000378:metabolism; D051381:Rats; D017207:Rats, Sprague-Dawley; D011942:Receptors, Adrenergic, alpha / Q000378:metabolism; D011943:Receptors, Adrenergic, beta / Q000378:metabolism; D051437:Renal Insufficiency / Q000378:metabolism* / Q000503:physiopathology*; D015398:Signal Transduction / Q000502:physiology; D013564:Sympathetic Nervous System / Q000502:physiology*
chemical_list: D015415:Biomarkers; D050484:Norepinephrine Plasma Membrane Transport Proteins; D011942:Receptors, Adrenergic, alpha; D011943:Receptors, Adrenergic, beta; C493226:Slc6a2 protein, rat; D051057:Proto-Oncogene Proteins c-akt; C496569:Grk2 protein, rat; D054769:G-Protein-Coupled Receptor Kinase 2; D048049:Extracellular Signal-Regulated MAP Kinases
references.citation: J Clin Invest. 2005 May;115(5):1275-80
references.pmid: 15841207
references.citation: Kidney Int. 1982 Jan;21(1):20-7
references.pmid: 7077944
references.citation: Circ Res. 2006 Dec 8;99(12):1367-75
references.pmid: 17110596
references.citation: Am J Physiol Heart Circ Physiol. 2000 Oct;279(4):H1635-44
references.pmid: 11009450
references.citation: J Mol Cell Cardiol. 2001 Apr;33(4):779-87
references.pmid: 11273730
references.citation: J Clin Invest. 1991 Jul;88(1):204-13
references.pmid: 1647415
references.citation: Cardiovasc Res. 2005 Jun 1;66(3):512-9
references.pmid: 15914116
references.citation: J Cell Biol. 1994 Sep;126(6):1565-72
references.pmid: 8089186
references.citation: Nephron. 1998 Sep;80(1):46-50
references.pmid: 9730702
references.citation: Mol Pharmacol. 2002 Apr;61(4):749-58
references.pmid: 11901213
references.citation: Mol Pharmacol. 2003 Jan;63(1):9-18
references.pmid: 12488531
references.citation: Proc Natl Acad Sci U S A. 2002 Sep 17;99(19):12333-8
references.pmid: 12237475
references.citation: Am J Physiol Renal Physiol. 2007 Dec;293(6):F1811-7
references.pmid: 17804485
references.citation: Clin Exp Pharmacol Physiol. 2007 Sep;34(9):884-8
references.pmid: 17645635
references.citation: Heart Fail Rev. 2000 Mar;5(1):17-25
references.pmid: 16228913
references.citation: Pediatr Nephrol. 2002 Aug;17(8):585-90
references.pmid: 12185462
references.citation: Eur J Pharmacol. 1991 Nov 13;208(3):231-8
references.pmid: 1685126
references.citation: J Biol Chem. 2002 Jun 21;277(25):22896-901
references.pmid: 11943770
references.citation: Am J Med Sci. 2002 Dec;324(6):296-304
references.pmid: 12495295
references.citation: Heart Fail Rev. 2007 Mar;12(1):66-86
references.pmid: 17387610
references.citation: Trends Biochem Sci. 2004 Nov;29(11):609-17
references.pmid: 15501680
references.citation: J Clin Invest. 2006 Apr;116(4):1005-15
references.pmid: 16585965
references.citation: J Am Coll Cardiol. 2000 Aug;36(2):608-17
references.pmid: 10933378
references.citation: Curr Opin Cardiol. 2007 Sep;22(5):443-9
references.pmid: 17762546
references.citation: J Biol Chem. 1997 Aug 22;272(34):21253-9
references.pmid: 9261135
references.citation: Circ Res. 2003 Nov 14;93(10):896-906
references.pmid: 14615493
references.citation: Annu Rev Pharmacol Toxicol. 1987;27:215-35
references.pmid: 3034138
references.citation: Cardiovasc Res. 2004 Aug 15;63(3):403-13
references.pmid: 15276465
references.citation: Nature. 2002 Jan 10;415(6868):206-12
references.pmid: 11805844
references.citation: Kidney Int Suppl. 2003 May;(84):S80-3
references.pmid: 12694316
references.citation: Am J Physiol Regul Integr Comp Physiol. 2002 May;282(5):R1356-63
references.pmid: 11959676
references.citation: Proc Natl Acad Sci U S A. 2003 Oct 14;100(21):12355-60
references.pmid: 14507992
references.citation: J Am Soc Nephrol. 2002 Jan;13(1):117-124
references.pmid: 11752028
references.citation: Mol Cell Biochem. 2004 Aug;263(1-2):5-9
references.pmid: 15524162
references.citation: J Pharmacol Sci. 2006;100(5):323-37
references.pmid: 16612046
references.citation: J Biol Chem. 1995 Apr 14;270(15):8902-9
references.pmid: 7721798
references.citation: Mol Pharmacol. 2002 May;61(5):1008-16
references.pmid: 11961118
references.citation: N Engl J Med. 2001 Jun 7;344(23):1750-7
references.pmid: 11396441
references.citation: J Pediatr. 2006 Nov;149(5):671-5
references.pmid: 17095341
references.citation: Brain Res. 1996 Dec 2;742(1-2):317-28
references.pmid: 9117411
references.citation: Circulation. 1994 Sep;90(3):1225-38
references.pmid: 8087932
references.citation: J Pharmacol Exp Ther. 1980 Nov;215(2):342-7
references.pmid: 6255126
references.citation: J Am Soc Nephrol. 2000 Aug;11(8):1469-1478
references.pmid: 10906160
references.citation: J Hypertens. 2006 May;24(5):905-13
references.pmid: 16612253
references.citation: J Clin Invest. 2007 May;117(5):1344-53
references.pmid: 17431507
references.citation: J Biol Chem. 1997 Jul 4;272(27):17223-9
references.pmid: 9202046
references.citation: Cardiovasc Res. 2006 Jan;69(1):46-56
references.pmid: 16288730
references.citation: Circulation. 2002 Mar 19;105(11):1354-9
references.pmid: 11901048
references.citation: N Engl J Med. 2000 Feb 24;342(8):541-9
references.pmid: 10684912
references.citation: Life Sci. 1986 Jul 14;39(2):169-79
references.pmid: 3014252
references.citation: Biochem Pharmacol. 1994 Aug 3;48(3):479-86
references.pmid: 8068035
references.citation: J Mol Cell Cardiol. 1996 Aug;28(8):1737-46
references.pmid: 8877783
references.citation: Hypertension. 1999 Jan;33(1 Pt 2):396-401
references.pmid: 9931136
references.citation: Hypertension. 1983 Jan-Feb;5(1):86-99
references.pmid: 6336721
references.citation: Mol Cell Biochem. 2003 Oct;252(1-2):229-37
references.pmid: 14577597
references.citation: Am J Physiol. 1986 May;250(5 Pt 2):H846-52
references.pmid: 3010745
references.citation: Kidney Int. 2003 Jul;64(1):52-62
references.pmid: 12787395
references.citation: Mol Pharmacol. 1997 Aug;52(2):306-13
references.pmid: 9271354
references.citation: J Hypertens. 2002 Jan;20(1):3-9
references.pmid: 11791019
references.citation: J Biol Chem. 1999 Aug 27;274(35):24858-64
references.pmid: 10455158